NCT02615847 Clinical Trial to Study the Safety and Tolerability of Memantin Mepha® in Sickle Cell Disease Patients Status COMPLETED Phase PHASE2
NCT02608580 Survey in a Population of Sickle Cell Disease Patients to Evaluate the Transition Between the Queen Fabiola Children Hospital and the CHU Brugmann Hospital, and the Quality of the Hospital Care Within the CHU Brugmann Hospital. Status COMPLETED Phase NA
NCT02580565 Prevalence of Problematic Use of Equimolar Mixture of Oxygen and Nitrous Oxide and Analgesics in the Sickle-cell Disease Status COMPLETED Phase N/A
NCT02578017 ElectroNic Hydroxyurea AdhereNCE: A Strategy to Improve Hydroxyurea Adherence in Patients With Sickle Cell Disease Status COMPLETED Phase NA
NCT02573714 Sub-dissociative Intranasal Ketamine for Pediatric Sickle Cell Pain Crises Status UNKNOWN Phase NA
NCT02567695 A Single-Dose Relative Bioavailability Study Of GBT440 300 mg Capsules in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02567682 Drug Interaction Study of GBT440 With Caffeine, S-warfarin, Omeprazole, and Midazolam in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02565082 Evaluation of the Hemostatic Potential in Sickle Cell Disease Patients Status COMPLETED Phase NA
NCT02560935 Primary Prevention of Stroke in Children With SCD in Sub-Saharan Africa II Status COMPLETED Phase PHASE3
NCT02539771 Sleep Study in Adult Patients With Major Sickle Cell Disease With Paroxysmal Nocturnal Events Status COMPLETED Phase NA
NCT02525107 Prevention of Vaso-occlusive Painful Crisis by Using Omega-3 Fatty Acid Supplements Status UNKNOWN Phase PHASE3
NCT02522104 Evaluation of the Impact of Renal Function on the Pharmacokinetics of SIKLOS ® (DARH) Status COMPLETED Phase PHASE4
NCT02504619 Allogeneic SCT of CordIn™, in Patients With Hemoglobinopathies Status TERMINATED Phase PHASE1/PHASE2
NCT02501447 Feasibility of a Stress Reduction Intervention Study in Sickle Cell Disease Status COMPLETED Phase NA